Testimonials 

Bio-Rad Laboratories, Inc., Jeanne McGowen, Senior Purchasing Manager

"There's a lot of antibody shops that are alike, here's what we have, it's off the shelf, take it or leave it.  But with Aragen it's alot more customized ... Right now, with this particular component, they're the only ones on the planet that can make it for us".  Taken from The Silcon Valley Business Journal .

Trellis Bioscience, President & Chief Executive Officer

Your cell line work did get scrutinized carefully by three large pharma suitors, with a "clean" outcome.

Arresto Bioscience (Now Gilead Sciences, Inc.), Victoria Smith, Ph.D.

The complex Oncology models performed at Aragen BioScience have been invaluable in moving our monoclonal antibody therapeutic programs forward.  We are looking forward to continuing to use Aragen’s services as our pre-clinical program evolves.

Biolex, Dr. Lynn Dickey, Ph.D., VP of Research and Technology Development

We continue to depend upon Aragen’s cell based assay expertise, and feel as if we are all on the same research team.
See research paper co-authored with Biolex

Neumedicines Inc, Lena A. Basile, Ph.D., J.D., President

Our selection of Aragen to provide cell line development services was based on their solid track record of success in this field.  Moreover, our interactions with Aragen scientists and staff further assured us that our project was in the hands of highly qualified professionals who could get the “get the job done.”

 

 

Return Home